Edition:
United Kingdom

Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

15.68USD
22 Oct 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$15.68
Open
$15.63
Day's High
$15.98
Day's Low
$15.32
Volume
44,830
Avg. Vol
55,319
52-wk High
$20.55
52-wk Low
$10.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.50 -0.663
Mar '18 0.00 -0.686
FY 2017 Dec '17 0.00 -0.925
Sep '17 0.30 -0.684
Jun '17 0.30 -0.660
Mar '17 0.30 -0.668
FY 2016 Dec '16 0.30 -0.560
Sep '16 0.30 -0.557
Jun '16 0.24 -0.524
Mar '16 0.21 -0.511
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 0.41 2.06 0.00 37.95
Quarter Ending Mar-19 4 13.32 29.00 0.00 --
Year Ending Dec-18 5 0.95 2.76 0.50 35.59
Year Ending Dec-19 5 60.83 135.00 9.70 72.32
Earnings (per share)
Quarter Ending Dec-18 5 -0.76 -0.65 -0.97 0.55
Quarter Ending Mar-19 5 -0.32 0.27 -0.70 --
Year Ending Dec-18 5 -2.77 -2.63 -3.04 -0.99
Year Ending Dec-19 5 -0.91 1.54 -2.37 -0.15
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.41 33.64
P/E High - Last 5 Yrs. -- 287.36 45.19
P/E Low - Last 5 Yrs. -- 89.75 23.75
Beta -0.12 0.93 0.88
Price to Sales (TTM) 252.25 124.37 5.83
Price to Book (MRQ) 3.76 15.29 4.89
Price to Tangible Book (MRQ) 3.78 14.52 6.51
Price to Cash Flow (TTM) -- 70.10 22.92
% Owned Institutions 49.44 14.25 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.54 5.40
Payout Ratio(TTM) -- 16.75 43.85

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 26.38 411.57 8.10
Sales (TTM) vs TTM 1 Yr. Ago 40.26 103.65 5.80
Sales - 5 Yr. Growth Rate -- 30.74 9.87
EPS (MRQ) vs Qtr. 1 Yr. Ago -25.96 24.06 23.38
EPS (TTM) vs TTM 1 Yr. Ago -14.13 -- --
EPS - 5 Yr. Growth Rate -- 37.62 10.92
Capital Spending - 5 Yr. Growth Rate -- 38.52 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.95 2.25
Current Ratio (MRQ) 4.65 5.36 3.05
LT Debt to Equity (MRQ) 0.00 34.93 12.76
Total Debt to Equity (MRQ) 0.00 36.74 17.18
Interest Coverage (TTM) -- -96.75 37.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.09 54.87
Gross Margin - 5 Yr. Avg. -- 49.02 52.39
EBITD Margin (TTM) -4,219.92 -- --
EBITD - 5 Yr. Avg -6,446.46 -579.09 11.01
Operating Margin (TTM) -4,220.23 -786.66 4.07
Operating Margin - 5 Yr. Avg. -6,468.54 -600.20 6.34
Pre-Tax Margin (TTM) -4,171.16 -748.77 5.12
Pre-Tax Margin - 5 Yr. Avg. -6,417.04 -605.79 6.78
Net Profit Margin (TTM) -4,171.28 -749.75 1.39
Net Profit Margin - 5 Yr. Avg. -6,415.84 -608.47 3.03
Effective Tax Rate (TTM) -- 23.52 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.69 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 41,297 22,677,535 808,218,600
Net Income/Employee (TTM) -1,722,596 1,703,754 95,058,584
Receivable Turnover (TTM) 19.87 20.77 5.78
Inventory Turnover (TTM) -- 2.37 3.63
Asset Turnover (TTM) 0.01 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.70 -1.39 10.90
Return on Assets - 5 Yr. Avg. -47.10 3.03 12.01
Return on Investment (TTM) -65.15 0.21 14.27
Return on Investment - 5 Yr. Avg. -52.69 2.10 15.60
Return on Equity (TTM) -65.34 1.17 15.99
Return on Equity - 5 Yr. Avg. -53.70 2.74 16.87
  1 Year 3 Year 5 Year
Sales % 59.19 144.78 --
EPS (TTM) % 0.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Stemline Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 66.56%
# of Holders: 127
Total Shares Held: 20,616,756
3 Mo. Net Change: -390,587
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 9
# Reduced Positions: 4
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.